Abstract
Objectives
This study investigated serum sialic acids for a predictive and diagnostic biomarker of diabetes mellitus (DM) in dogs and its prognostic value with ethanolic extract of Anogeissus leiocarpus.
Design
Four groups of 3 dogs were used; non-diabetic controls (ND), diabetic-untreated (DU), diabetic insulin-treated (DI) and diabetic extract-treated (DE). Free serum sialic acids (FSSA) and erythrocyte surface sialic acids (ESSA) were assayed in all groups, pre-and post-induction of hyperglycaemia and results were presented as means ± standard error of means (SEM) and subjected to ANOVA using Tukey’s post-hoc tests with GraphPad Prism® statistical package.
Results
FSSA increased in DU and plateaued at third week (61.8 ± 0.41 μg/ml), (P < 0.002) with additional 38.2 μg/ml (62%) generated, coinciding with hyperglycaemia. FSSA of DI increased but declined to 22.3 ± 1.55 μg/ml. Extract of Anogeissus leiocarpus effectively modulated FSSA in DE as increased value declined to 21.4 ± 0.78 μg/ml. Pre-induction DU ESSA (8.27 ± 0.11 μg/ml) significantly (P < 0.002) decreased by third week (2.33 ± 1.49 μg/ml), coinciding with hyperglycaemia. Strong negative correlation coefficient (r = −0.92) occurred between DU’s FSSA and ESSA and ND (P < 0.03). Sialic acid expression in dog’s insulin dependent diabetes mellitus (IDDM) is 18% lower than normal. Extract of A. leiocarpus restored ESSA completely. ESSA cleaved in DU, 5.94 μg/ml (72%), could not account for the extra FSSA (32.26 μg/ml); liver and kidneys are contributors.
Conclusion
FSSA predicts canine DM.
Similar content being viewed by others
References
World Health Organization. Global report on diabetes. 1. Diabetes Mellitus–epidemiology. 2. Diabetes Mellitus – prevention and control. 3. Diabetes, Gestational. 4. Chronic Disease. 5. Public Health. I. World Health Organization. France 2016.
World Health Organization (WHO). Global report on diabetes. Geneva, Switzerland 2018.
International Diabetes Federation, IDF Diabetes Atlas. 8th ed. 2017.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Show JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49.
Ihedioha JI, Enahoro G. Prevalence of diabetes mellitus and reference values for the fasting blood glucose levels of locally available breeds of dogs in Warri, Nigeria. Comp Clin Pathol. 2019;28:1107–12.
Marmett B, Nunes RB. Resistance and aerobic training in the treatment of type 2 diabetes mellitus. J Diabetes Metab Disord Control. 2017;4:00126.
Dadrass A, Salamat KM, Hamidi K, Azizbeigi K. Anti-inflammatory effects of vitamin D and resistance training in men with type 2 diabetes mellitus and vitamin D deficiency: a randomized, double-blinded, placebo-controlled clinical trial. J Diabetes Metab Disord. 2019;18(2):323–31.
Traving C, Schauer R. Structure, function and metabolism of sialic acids. Cell Mol Life Sci. 1998;54:1330–49.
Schauer R. Achievements and challenges of sialic acid research. Glycoconj J. 2000;17:485–99.
Kishore BK, Gejyo E, Arakawa M. Altered glycosylation and sialylation of serum proteins and lipid bound sialic acids in chronic renal failure. Postgrad Med. 1983;59:551–5.
Forte P, Copland M, Smith LM, Miline F, Sutherland J, Benjamin N. Basic nitric oxide synthesis in essential hypertension. Lacent. 1997;349(9055):837–42.
Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.
Varki A. Sialic acids in human health and disease. Trends Mol Med. 2008;14(8):351–60.
Varki A. Essentials of glycobiology. 2nd ed. New York: Cold spring harbor laboratory press, cold spring harbor; 2009.
Shahid SM, Mahboob T. Correlation between frequent risks factors of diabetic nephropathy and serum sialic acid. Asian J Biochem. 2006;1(3):244–50.
Englyst NA, Crook MA, Lumb P, Stears AJ, Masding MG, Wootton SA, et al. Percentage of body fat and plasma glucose predict plasma sialic acid concentration in type 2 diabetes mellitus. Metab. 2006;55:1165–70.
El-Sayed MS, El Badawy A, Abdelmoneim RO, Mansour AE, Khalil ME, Darwish K. Relationship between serum sialic acid concentration and diabetic retinopathy in Egyptian patients with type 2 diabetes mellitus. Benha Med J. 2018;35:257–63.
Yarema K. The sialic acid pathway in human cells. Baltimore: John Hopkins University; 2006.
Prajna K, Ashok KJ, Srinidhi R, Shobith KS, Tirthal RS, Mohamedi B, et al. Predictive value of serum Sialic acid in Type-2 diabetes mellitus and its complication (nephropathy). J Clin Diagn Res. 2013;7(11):2435–7.
Vahalkar GS, Haldankar VA. RBC membrane composition in insulin dependent diabetes mellitus in context of oxidative stress. Indian J Clin Biochem. 2008;23(3):223–6.
Mazzanti L, Rabini RA, Salvolini E, Tesei M, Martarelli D, Venerando B, et al. Sialic acid, diabetes, and aging: a study on the erythrocyte membrane. Metab. 1997;46(1):59–61.
Moretti N, Rabini RA, Nanetti L, Grechi G, Gurzi MC, Cester N, et al. Sialic acid content in erythrocyte membranes from pregnant women affected by gestational diabetes. Met-Clin Exp. 2002;51(5):605–8.
Onoja US, Ugwu CC, Uzor PF, Nweze IE, Omeje EO, Nnamani PO, et al. Effect of Anogeissus leiocarpus guill and perr leaf on hyperglycaemia and associated dyslipidaemia in alloxan-induced diabetic rats. Dhaka Uni J Pharm Sci. 2018;17(1):65–72.
Motto EA, Lawson-Evi P, Kantati Y, Eklu-Gadegbeku K, Aklikokou K, Gbeassor M. Antihyperglycemic activity of total extract and fractions of Anogeissus leiocarpus. J Drug Deliv Ther. 2020;10(3):107–13.
Num SM, Oladele SB, Esievo KAN, Useh NM. Some observations in Wistar rats administered ethanol extracts of the stem barks of Anogeissus leiocarpus. Asian J Pharm Toxicol. 2014;2(03):4–10.
Evans WC. Trease and Evans’ pharmacognosy. 14th ed. Singapore: W.B. Saunders Co. Ltd; 1996. p. 119–59.
Trease K, Evans WC. Textbook of Pharmacognosy. 14th ed. London: Balliere, Tindall; 1996.
Harbone JB. Phytochemical methods: a guide to modern techniques for plant analysis. 3rd ed. London: Chapman and Hill; 1973. p. 279.
Bohm BA, Koupai-Abyazani R. Flavonoids and condensed tannins from leaves of Vaccinium raticulatum and Vaccinium calcymium (Ericaceae). Pac Sci. 1994;48:458–63.
Obadoni B, Ochuko PO. Phytochemical studies and comparative efficacy of the crude extract of some homeostatic plants in Edo, Delta states of Nigeria. Global J Pure Appl Sci. 2001;8:203–8.
Van-Burden TP, Robinson WC. Formation of complexes between protein and tannic acids. J Agric Food Chem. 1981;1:77.
Aluwong T, Ayo JO, Kpukple A, Oladipo OO. Amelioration of hyperglycaemia, oxidative stress and dyslipidaemia in alloxan-induced diabetic wistar rats treated with probiotic and vitamin C. Nutrients. 2016;8(5):151.
Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of haemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963;100:119–30.
Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959;234:1971–5.
Aminoff D. Methods for the quantitative estimation of N-acetyneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961;81:384–92.
Izumida Y, Seiyama A, Maeda N. Erythrocyte aggregation: bridging by macromolecules and electrostatic repulsion by sialic acid. BBA – Biomembranes. 1991;1067:221–6.
Poddar A, Ray S. Serum sialic acid levels in diabetic subjects: a promising screening tool for microvascular and macrovascular complications in diabetes. Int J Sci Res. 2015;4:2042–4.
Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M. Risk factors for microvascular complications of diabetes among south Indian subjects with type 2 diabetes—the Chennai urban rural epidemiology study (CURES) eye Study-5. Diabetes Technol Therapeutics. 2010;12(10):755–61.
Subzwari MJ, Qureshi MA. Relationship between sialic acid and microvascular complications in type 2 diabetes mellitus. Proceeding SZPGMI. 2010;24(2):79–83.
Divija DA, Rajeshwari A, Nusrath A. Correlation of serum sialic acid with glycaemic status in diabetic retinopathy. Int J Bioassays. 2014;3:1789–93.
Kumar SP, Latha JM, Amarendra M, Benerji GV. A study of serum sialic acid in noninsulin dependent diabetes mellitus. Indian J Basic and Appl Med Res. 2015;4:612–9.
Ghosh J, Datta S, Pal M. Role of sialic acid in prediction of diabetic retinopathy. Al Ameen J Med Sci. 2016;9(1):58–64.
Rahman I, Malik AS, Bashir M, Khan R, Igbal M. Serum sialic acid changes in non-insulin dependent diabetes mellitus (NIDDM) patients following better melon (Momordica charantia) and rosiglitazone (Avanda) treatment. Phytomedicine. 2009;16:401–5.
Venerando B, Fiorilli A, Croci G, Tringali C, Goi G, Mazzanti L. Acidic and neutral sialidase in the erythrocyte membrane of type II diabetic patients. Blood. 2002;99:1064–70.
Alghamdi F, Guo M, Abdulkhalek S, Crawford N, Amith SR, Szewezu MR. A novel insulin receptor-signaling platform and its link to insulin resistance and type of diabetes. Cell Signal. 2014;26(4):1355–68. https://doi.org/10.1016/j.cellsig.2014.02.015.
Nayak BS, Duncan H, Lalloo S, Maraj K, Matumungal V, Matthews F, et al. Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy. Vasc Health Risk Manag. 2008;4(1):243–7.
Khalili P, Sundstrom J, Jendle J, Lundin F, Jungner I, Nilsson PM. Sialic acid and incidence of hospitalization for diabetes and its complications during 40 years of follow-up in a large cohort: the Varmland survey. Prim Care Diabetes. 2014;8(4):352–7.
Ibrahim MA, Abdulkadir A, Onajah A, Sani L, Adamu A, Abdulahi H. Modulation of sialic acid levels among some organs during insulin resistance or hyperglycemias. Mol Cell Biochem. 2015;411:235–9. https://doi.org/10.1007/s11010-015-2585-x.
Gokmen SS, Klicli G, Ozcelik F, Ture M, Gulen S. Association between serum total and lipid-bound sialic acid concentration and the severity of coronary atherosclerosis. J Lab Clin Med. 2002;140(2):110–8.
Sabzwari MJ, Ahmad M, Majeed MT, Riaz M, Umair M. Serum sailic acid concentration and type 2 diabetes mellitus. Professional Med J. 2006;13(4):508–10.
Esievo KAN. Veterinary clinical pathology, vol. 37. 1st ed. Ibadan: Spectrum Books; 2017. p. 110–1.
Akah PA, Alemji JA, Salawu OA, Okoye TC, Offiah NV. Effects of Vernonia amygdalina on biochemical and haematological parameters in diabetic rats. Asian J Med Sci. 2009;1(3):108–13.
Hillson R. Diabetes and the blood red cells. Pract Diabetes. 2015;32:124–6.
Yaari A. Mobility of human red blood cells of different age groups in an electric field. Blood. 1969;33:159–63.
Greenwalt TJ, Steane EA. Quantitative haemagglutination. IV. Effect of neuraminidase treatment on agglutination of blood group antibodies. Br J Haematol. 1973;25:207–15.
Acknowledgements
The authors acknowledge the support of the Faculty of Veterinary Medicine Post Graduate Committee, Ahmadu Bello University and Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital Shika.
Funding
This study was partly funded by Tertiary Education Trust Fund (TETFUND) of Nigeria.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All applicable international, national and institutional guidelines for the care and use of animals were followed. This article contains studies with animal subjects performed by the authors and ethical approval for this study was provided by Ahmadu Bello University Committee on Animal Use and Care (ABUCAUC) (Ethical clearance No ABUCAC/2019/16).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Esievo, K.A.N., Num-Adom, S.M., Adamu, S. et al. Elevated serum sialic acids, a potent biomarker of alloxan-induced type 1 diabetes in dogs by ethanolic extract of Anogeissus leiocarpus. J Diabetes Metab Disord 20, 179–186 (2021). https://doi.org/10.1007/s40200-021-00726-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-021-00726-1